EUVIMEDEUVIMED entdecken
Crossref

Progress and problem in the clinical application of pharmacogenomics

Feng Wang, Machicheng Bao, Jing Xu, Jia Liu

New Medicine · 2023

DOI: 10.61958/nmam6815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New Medicine, 2023. Verfasst von Feng Wang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the emergence of various diseases, the use of clinical drugs has become common. Previously, a lot of unreasonable drug use increasingly becomes a serious concern, especially when the efficacy of drugs can't be maximized and side effects can't be minimized. In recent years, pharmacogenomics has effectively helped physicians and pharmacists predict drug efficacy and estimate drug dose by correlating individual genetic information with drug kinetics and pharmacodynamics. In addition, it is helpful to adjust drug administration regimens in time and prevent the occurrence of adverse drug reactions, to guide patients to use drugs rationally. This review analyzes the latest progress and outstanding problems in the clinical application of pharmacogenomics in order to provide a reference for its rational clinical application and promotion.

Zitieren

APA

Wang, F., Bao, M., Xu, J., & Liu, J. (2023). Progress and problem in the clinical application of pharmacogenomics. New Medicine. https://doi.org/10.61958/nmam6815

Vancouver

Wang F, Bao M, Xu J, Liu J. Progress and problem in the clinical application of pharmacogenomics. New Medicine. 2023. doi:10.61958/nmam6815

BibTeX
@article{Wang2023,
  author = {Wang, Feng and Bao, Machicheng and Xu, Jing and Liu, Jia},
  title = {Progress and problem in the clinical application of pharmacogenomics},
  journal = {New Medicine},
  year = {2023},
  doi = {10.61958/nmam6815}
}
Kostenlos starten →